The European Medicines Agency have published: Scientific guideline: Draft guideline on implementation of risk assessment requirements to control elemental impurities in veterinary medicinal products, draft: consultation open.

In order to allow time for regulators to elaborate guidance on the appropriate approach for a risk assessment for a veterinary medicinal product, the CVMP has adopted the following measured approach to the implementation of the monograph to existing veterinary products. The phased-in implementation of the risk assessment of elemental impurities in veterinary medicinal products is to be in accordance with the decision tree indicated in this document. More information is available on the EMA’s website.